glp 1 multiple endocrine neoplasia Semaglutide: What we know about safety and cancer risk Glucagon-like peptide-1 receptor agonists –
Description
The Journal of Clinical Investigation, 101, 515520

Li ZY, Zhang N, Wen S, Zhang J, Sun XL, Fan XM et al (2017) Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome

Recent interest has emerged around GLP-1 receptor agonists like Ozempic for fibromyalgia management, driven by growing evidence that these medications activate anti-inflammatory pathways beyond glucose control

That being said, BMI is just one part of the equation and often doesnt reflect a patients entire medical story

Reviewed June 13, 2023

The ones you may feel shy to bring up in a doctor visit
